Stock VEC VECTURA GROUP
Add to a list
To use this feature you must be a member
Log inSign up

Vectura Group

Equities

VEC

GB00BKM2MW97

Delayed London S.E.
Other stock markets
 11:35:22 2021-10-18 am EDT 		5-day change 1st Jan Change
164.8 GBX -.--% Intraday chart for Vectura Group -.--% -.--%
Apr. 16 Mundipharma and Vectura Announce Plans to Reformulate Fluticasone Propionate/Formoterol Fumarate CI
2021 EnBiotix, Inc. announced that it has received $11 million in funding from Vectura Group plc, Cystic Fibrosis Foundation CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Vectura Group

Mundipharma and Vectura Announce Plans to Reformulate Fluticasone Propionate/Formoterol Fumarate CI
EnBiotix, Inc. announced that it has received $11 million in funding from Vectura Group plc, Cystic Fibrosis Foundation CI
Philip Morris CEO does not need M&A to hit smoke free goals RE
Philip Morris International : Raises Lobbying Concerns Over $1.4 Billion Vectura Deal MT
PMI Global Services, Inc Completes the Acquisition of Vectura Group plc CI
Vectura Group plc's Equity Buyback announced on September 10, 2019, has expired. CI
PMI Global Services, Inc. completed the acquisition of Vectura Group plc from AXA Investment Managers S.A., Legal & General Investment Management Limited, The Vanguard Group, Inc. and others. CI
Vectura Group plc(LSE:VEC) dropped from S&P Global BMI Index CI
Philip Morris International : Extends Offer Period For Vectura Takeover MT
Morrisons takeover battle will go to UK auction on Oct. 2 RE
Vectura Group plc(LSE:VEC) dropped from FTSE 250 Index CI
Vectura Group plc(LSE:VEC) dropped from FTSE 250 (Ex Investment Companies) Index CI
Vectura Group plc(LSE:VEC) dropped from FTSE 350 (Ex Investment Companies) Index CI
Vectura Group plc(LSE:VEC) dropped from FTSE 350 Index CI
Vectura Group plc(LSE:VEC) dropped from FTSE All-Share Index CI
Vectura Group plc(LSE:VEC) dropped from FTSE techMARK All-Share Index CI
Philip Morris International : to Delist Britain's Vectura on Oct. 19 MT
Vectura : Pharmaceutical Conference Bans Vectura After Takeover By Philip Morris MT
Augean : Buyout battle for waste management firm Augean headed to auction - regulator RE
Today on Wall Street: US economy shows resilience, while China falters Our Logo
Philip Morris seals deal for UK's Vectura despite health group concerns RE
FTSE Rises, Ashtead Gains After 1Q Profit Boost, Guidance Increase DJ
Philip Morris Confirms Majority of Vectura Shareholders Agree to Takeover CI
Philip Morris International : Secures Vectura Takeover with 75% support MT
BOE Expected to Leave Policy Unchanged Next Week DJ

Chart Vectura Group

Chart Vectura Group
More charts

Company Profile

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. VEC Stock
  4. News Vectura Group
  5. Vectura : Extends Period For Conditions In Possible Takeover By Carlyle